Good Summary Cos. will be used I think director in common should be mentioned.A lot of info has been tabled by BBIG not available to market.Second the dislisting will affect some 3000 Sh.
OAR Chris Judd's Talk Ya Book: Orthocell building on 'enormous potential' with steady growth - and US push to come
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025